Biotechnology

Advanced Therapy Medicinal Products (ATMPs) are changing the face of medicine, but with all the opportunity and rapid change comes a host of challenges. Here’s a look at the state of the ATMP industry and important considerations for manufacturers chasing success.

The cell and gene industry is a competitive, exciting field that is centered on rapidly evolving science. It’s a vibrant world with unlimited possibilities—and with clever interior design, its facilities can reflect that same energy.

Many of the life sciences trends that are driving innovation today were here pre-COVID, but the pandemic was an accelerant. For all that it took, it gave life science researchers and developers new momentum, and from that momentum, hope.

How do classic plasma fractionation separation methods compare? And what comes next?

Facing pressure in the ATMP marketplace? Multimodal manufacturing is your solution for that.

Here’s the thing we figured out about offering a single solution, though: when you try to fit everyone, you wind up fitting no one.

As part of a broad strategy to accelerate the response to the global pandemic of COVID-19, the government has been selecting the most promising manufacturing candidates and providing coordinated government support to scale up production capacity immediately—Operation Warp Speed (OWS).